Thomas Pike - Jan 9, 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Pres & CEO Clinical Business
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Thomas Pike
Stock symbol
LH
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
4
Date filed
1/11/2023, 12:42 PM
Previous filing
Dec 2, 2022
Next filing
Mar 1, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Award $0 +17K $0.00 17K Jan 9, 2023 Common Stock 17K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024.